Who is the CEO of CREATE Medicines?

The Co-Founder and Chief Executive Officer of CREATE Medicines is Daniel Getts, Ph.D.

How many employees does CREATE Medicines have?

CREATE Medicines has approximately 39 employees.

What industry is CREATE Medicines in?

CREATE Medicines operates in Biotechnology.

Is CREATE Medicines still active?

Yes, CREATE Medicines was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.

How do I sell to CREATE Medicines?

Research CREATE Medicines's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details.

Data Surfer

How it works Insights Pricing FAQ Contact Login

CREATE Medicines

Biotechnology

39 employees

createmedicines.com

Verified active February 2, 2026

Key Highlights

CREATE Medicines pioneers multi-immune programming using a versatile in vivo CAR platform.
Their proprietary mRNA-LNP CARs enable direct programming of T cells, NK cells, and myeloid cells.
The company utilizes targeted receptor/LNP technologies for in vivo cell programming.
CREATE Medicines has shown first-in-human evidence of cell uptake and expression.
Their products have demonstrated tolerable repeat dosing in initial human studies.

About CREATE Medicines

CREATE Medicines is pioneering multi-immune programming with its versatile in vivo CAR platform. Their proprietary mRNA-LNP CARs and targeted receptor/LNP technologies enable direct programming of T cells, NK cells, and myeloid cells within the body. The company's products have demonstrated first-in-human evidence of uptake, expression, and tolerable repeat dosing.

Leadership Team

Daniel Getts

Co-Founder and Chief Executive Officer

Allan Shaw

Chief Financial & Business Officer

Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.

Technology Stack

mRNA-LNP CARs
targeted receptor/LNP technologies
in vivo CAR platform

Why Contact CREATE Medicines?

CREATE Medicines is a biopharmaceutical company pioneering multi-immune programming using a proprietary in vivo CAR platform, specifically mRNA-LNP CARs and targeted receptor/LNP technologies to progr

Who Should Contact CREATE Medicines for Business?

Biopharmaceutical research and development focusing on proprietary mRNA-LNP CAR and targeted receptor/LNP technologies for in vivo immune programming.

More Biotechnology Companies

Congruence Therapeutics

40 employees

Spark Therapeutics, Inc.

View all Biotechnology companies

Frequently Asked Questions

Who is the CEO of CREATE Medicines?: The Co-Founder and Chief Executive Officer of CREATE Medicines is Daniel Getts, Ph.D.
What does CREATE Medicines do?: CREATE Medicines is a biopharmaceutical company pioneering multi-immune programming using a proprietary in vivo CAR platform, specifically mRNA-LNP CARs and targeted receptor/LNP technologies to program T cells, NK cells, and myeloid cells directly within the body.
How many employees does CREATE Medicines have?: CREATE Medicines has approximately 39 employees.
What industry is CREATE Medicines in?: CREATE Medicines operates in Biotechnology.
Is CREATE Medicines still active?: Yes, CREATE Medicines was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to CREATE Medicines?: Research CREATE Medicines's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.